My Watchlist

Top Indices

Nasdaq Composite

SPX

My Portfolio

10x Genomics, Inc. - Common Stock (NQ:TXG)

17.87 -0.07 (-0.39%)

Streaming Delayed Price Updated: 4:00 PM EST, Dec 3, 2025 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about 10x Genomics, Inc. - Common Stock

< Previous 1 2

...

4 5 6 7 8 9 10 11 Next >

Elliott Wave Technical Analysis: 10x Genomics Inc. Thursday, September 28 ↗

September 28, 2023

We have been correcting as forecasted, after what seems to be a five wave move to the upside in either wave (1) or (A). Looking for a corrective wave to then resume higher.

Via Talk Markets

Where 10x Genomics Stands With Analysts ↗

September 19, 2023

Via Benzinga

Cathie Wood Buys Shares Of Pacific Biosciences, Reduces Exposure To DraftKings And Genius Sports ↗

August 07, 2023

Via Benzinga

Buy-Zone-Adjacent 10x Genomics Tops Sales Views, But There's A Caveat ↗

August 03, 2023

The company is working in the nascent research area of spatial biology, which could unlock the answers to some diseases.

Via Investor's Business Daily

Earnings Scheduled For August 3, 2023 ↗

August 03, 2023

Companies Reporting Before The Bell • Cedar Fair (NYSE:FUN) is likely to report quarterly earnings at $1.10 per share on revenue of $512.74 million.

Via Benzinga

Earnings Outlook For 10x Genomics ↗

August 02, 2023

Via Benzinga

10x Genomics Inc. (NASDAQ: TXG) Sets New 52-Week High in Thursday Session

July 20, 2023

Via Investor Brand Network

Where 10x Genomics Stands With Analysts ↗

July 13, 2023

Via Benzinga

Looking Into 10x Genomics's Return On Capital Employed ↗

May 24, 2023

Via Benzinga

7 Analysts Have This to Say About 10x Genomics ↗

May 18, 2023

Via Benzinga

Market Rally Under Pressure As Yields Soar; Amazon, ELF, Caterpillar Are Earnings Winners: Weekly Review ↗

August 04, 2023

Amazon, ELF and CAT were earnings winners, but there were big losers too.

Via Investor's Business Daily

Brace for Impact: These 5 Overvalued Stocks Face Bearish Pressure In Impending Market Reversal ↗

June 20, 2023

Via Benzinga

Cathie Wood Is Buying the SEC Lawsuit Dip in Coinbase (COIN) Stock ↗

June 07, 2023

Coinbase and the crypto industry at large is at war with regulators. But Cathie Wood is still buying shares of COIN stock.

Via InvestorPlace

10x Genomics: Q1 Earnings Insights ↗

May 03, 2023

Via Benzinga

Earnings Preview: 10x Genomics ↗

May 02, 2023

Via Benzinga

Elliott Wave Technical Analysis:10X Genomics Inc. ↗

April 06, 2023

Looking for short-term shorts as we should start to unfold lower.

Via Talk Markets

Why Are NanoString Technologies Shares Falling Today ↗

May 18, 2023

Wednesday, 10x Genomics Inc (NASDAQ: TXG) won an injunction in its patent litigation against NanoString Technologies Inc (NASDAQ: NSTG) and its German subsidiary regarding CosMx

Via Benzinga

Why Shares of NanoString Technologies Are Falling Thursday ↗

May 18, 2023

The company lost a patent ruling in Germany to life sciences competitor 10x Genomics.

Via The Motley Fool

3 DNA Stocks to Buy for the Synthetic Biology Revolution ↗

May 14, 2023

Synthetic biology is a growing industry. The big winners will be DNA stocks that are able to sell to everyone, not just a small niche.

Via InvestorPlace

Benzinga's Top Ratings Upgrades, Downgrades For May 10, 2023 ↗

May 10, 2023

Via Benzinga

Analyst Expectations for 10x Genomics's Future ↗

March 31, 2023

Via Benzinga

Elliott Wave Technical Analysis: 10x Genomics ↗

March 13, 2023

Looking for upside resumption soon or else the count will be invalidated.

Via Talk Markets

10x Genomics Earnings Perspective: Return On Capital Employed ↗

December 19, 2022

Via Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For March 31, 2023 ↗

March 31, 2023

Via Benzinga

KBR, Twilio, Roku And Other Big Stocks Moving Higher On Thursday ↗

February 16, 2023

U.S. stocks traded lower, with the Dow Jones dropping over 250 points on Thursday. Here are some big stocks recording gains in today’s session.

Via Benzinga

3 CRISPR Stocks to Buy Now Or You’ll Be Kicking Yourself Later ↗

February 02, 2023

CRISPR stocks are heating back up after a difficult 2022. These three names should be at the top of your watchlist.

Via InvestorPlace

Benzinga's Top Ratings Upgrades, Downgrades For February 2, 2023 ↗

February 02, 2023

Via Benzinga

Elliott Wave Technical Analysis: 10x Genomics Inc. ↗

January 10, 2023

It looks like we are extending higher into wave {iii}, looking for additional longs into wave {v}.

Via Talk Markets

These Were The Five Best And Worst Performing Mid-Cap Stocks In November 2022 ↗

December 11, 2022

In November, the Dow Jones gained around 7%, the S&P 500 gained 8.4%, and the Nasdaq gained 9.1%. The S&P Mid-Cap 400 performance was in line with major indices. Let’s take a look at the five best and...

Via Talk Markets

Benzinga's Top Ratings Upgrades, Downgrades For December 14, 2022 ↗

December 14, 2022

Via Benzinga

< Previous 1 2

...

4 5 6 7 8 9 10 11 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.